Added benefits of long-term treatment of methylphenidate modified-release long-acting formulation in adults with ADHD

被引：0
|
作者：
Huss, M. [1 ]
Ginsberg, Y. [2 ]
Arngrim, T. [3 ]
Philipsen, A. [4 ]
Gandhi, P. [5 ]
Chen, C. W. [6 ]
Kumar, V. [6 ]
机构：
[1] Univ Med, Dept Child & Adolescent Psychiat, Mainz, Germany
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[3] Private Clin, Aarhus, Denmark
[4] Univ Med Ctr, Freiburg, Germany
[5] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70325-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.1.g.014
引用
收藏
页码：S210 / S210
页数：1
相关论文
共 50 条
  • [1] Nisoldipine modified-release: another long-acting calcium antagonist formulation
    Drugs & Therapy Perspectives, 1997, 9 (1) : 1 - 5
  • [2] Efficacy and safety of OROSO methylphenidate in adults with ADHD the long-acting methylphenidate in adult ADHD (lamda) trial
    Medori, R.
    Kooij, S.
    Ramos-Quiroga, J. A.
    Buitelaar, J.
    Lee, E.
    Casas, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCII - XCIII
  • [3] A long-term safety study of prolonged-release methylphenidate in adults with ADHD
    Schaeuble, B.
    Singh, J.
    Adler, L. A.
    Orman, C.
    Pandina, G. J.
    Palumbo, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S679 - S679
  • [4] Aptensio XR - Another Long-Acting Methylphenidate for ADHD
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1473): : 101 - 103
  • [5] Long-term benefits of treatment with risperidone long-acting injection (LAI) in patients with schizophrenia
    Turner, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 71 - 71
  • [6] An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations
    Childress, Ann C.
    Komolova, Marina
    Sallee, F. Randy
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 937 - 974
  • [7] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [8] LONG-TERM SAFETY OF METHYLPHENIDATE HYDROCHLORIDE MODIFIED RELEASE (MPH-LA) IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS
    Ginsberg, Y.
    Tvedten, T.
    Arngrim, T.
    Philipsen, A.
    Gandhi, P.
    Chen, C. W.
    Kumar, V.
    Huss, M.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [9] Long-acting methylphenidate for the treatment of adults with attention deficit hyperactivity disorder
    Asherson, P
    Libretto, SE
    BRITISH JOURNAL OF DEVELOPMENTAL DISABILITIES, 2004, 50 (99): : 143 - 151
  • [10] LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN
    CHNG, LJC
    SANDLER, LM
    KRAENZLIN, ME
    BURRIN, JM
    JOPLIN, GF
    BLOOM, SR
    BRITISH MEDICAL JOURNAL, 1985, 290 (6464): : 284 - 285
12345